ArticleClinical drug investigation2018

Improvements in Quality-Adjusted Life Years and Cost-Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study.

Eiichiro Kamagata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.